Viewing Study NCT07086456


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-02 @ 1:49 AM
Study NCT ID: NCT07086456
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2025-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module